Investor Portal
Vynleads, Inc. (OTCQB: VYND) is a publicly traded wellness technology company focused on AI-powered metabolic health solutions.
Stock Information
Ticker Symbol: VYND
Exchange: OTCQB
Industry: Health Technology
Company Overview
Vynleads provides lifestyle-first, educational wellness support programs for chronic illness prevention and management, with a primary focus on metabolic health and diabetes. The company's flagship product is the Done With Diabetes 8-week protocol, featuring AI-powered coaching through Dr. Smith AI Coach.
Recent News & Press Releases
- Vynleads CEO Alex Mannine Featured on KENS 5's Healthy SA
- White House Charts a "New Golden Age" for American Science
- Vynleads Launches Done With Diabetes™ App
- Vynleads Unveils DWX Lifestyle Blueprint Platform
- Vynleads Graduates to OTCQB
- SEC Effective Announcement
- DWD Protocol COVID Support
- Natural Ways to Boost Immunity
- Reducing Fear & Anxiety During Pandemic
- Coronavirus Preparation for Diabetes
- DWD Web Commercials
- HealthCorps Gala 2018
- Dr. Song Joins Medical Advisory
Service Providers
Independent Auditor
Stephano Slack LLC
125 Strafford Avenue, Suite 200, Wayne, PA 19087
Phone: (610) 687-1600
Transfer Agent
VStock Transfer LLC
18 Lafayette Place, Woodmere, NY 11598
Phone: (212) 828-8436
Investor FAQ
What is Vynleads stock ticker symbol?
Vynleads trades on the OTCQB under the ticker symbol VYND.
What does Vynleads do as a company?
Vynleads is a wellness technology company that provides AI-powered metabolic health solutions for chronic illness prevention and management.
Press Releases & News
- America's New Dietary Guidelines Say Eat Real Food — the Foundation Done With Diabetes™ Was Built On
- Vynleads Unveils Its World Model of Behavior Change: Synthetic Lives in Simulation, Value in the Real World
- Vynleads CEO Alex Mannine Featured on KENS 5's Healthy SA: Using AI Chatbots to Support Your Health Journey
- White House Charts a “New Golden Age” for American Science — With AI
- Vynleads Launches Done With Diabetes™ App
- Vynleads Unveils Done With Lifestyle Blueprint™ Technology Platform
- Vynleads Graduates to OTCQB Venture Market
- DWD Protocol Can Support Type 2 Diabetics Amidst Health Uncertainty
- Natural Ways to Boost Immunity and Protect Against Viruses
- Reducing Fear, Anxiety, and Panic Amidst a Pandemic
- How to Prepare for the Coronavirus with Diabetes
- Vynleads SEC Effective Announcement
- DWD Team Films New Web Commercials for Diabetes Awareness
- Vynleads Supports HealthCorps at Annual Gala
- Dr. Erica Song, M.D. Joins Vynleads Medical Advisory Team